Activity Not Available
The activity "From Pathways to PROs: Translating the Latest Evidence for Current and Emerging JAK Inhibitors to Clinical Practice" is currently unavailable.
Please refer to the Educational Activities Menu for a complete list of available offerings.
Please choose an activity format
Available formats
From Pathways to PROs: Translating the Latest Evidence for Current and Emerging JAK Inhibitors to Clinical Practice
Live Symposium
11/20/2018 - 11/20/2019
From Pathways to PROs: Translating the Latest Evidence for Current and Emerging JAK Inhibitors to Clinical Practice
Participate by Phone
Live Event: 11/20/2018
Dial-in:
Post-Event Replay:
Dial-in:
From Pathways to PROs: Translating the Latest Evidence for Current and Emerging JAK Inhibitors to Clinical Practice
From Pathways to PROs: Translating the Latest Evidence for Current and Emerging JAK Inhibitors to Clinical Practice
From Pathways to PROs: Translating the Latest Evidence for Current and Emerging JAK Inhibitors to Clinical Practice